As previously reported, our screening approach for inhibitors of MLL-r leukemia resulted in the identification of another novel compound, CCI-007, that demonstrated cytotoxic activity against a subset of MLL-r and CALM-AF10 translocated leukemia cell lines [10]. The gene discussed is KMT2A; the disease is leukemia.